Ultragenyx Pharmaceutical (RARE) Operating Income (2013 - 2026)
Ultragenyx Pharmaceutical (RARE) recorded Operating Income of -$75 million in Q2 2026, compared with -$108 million a year earlier.
Powered by 
Analysis
Ultragenyx Pharmaceutical (RARE) Operating Income (2013 - 2026) Analysis & Trends
On a TTM basis, Ultragenyx Pharmaceutical's Operating Income came in at -$528.17 million as of Jun 30, 2026; for FY2025, it was -$535 million.
- Across earlier years, Operating Income came in at -$536 million in FY2024, -$569 million in FY2023, -$648.92 million in FY2022 and -$381.74 million in FY2021.
- The Q2 2026 figure is the highest quarterly Operating Income since Q3 2020.
- Per Business Quant, the preceding three quarters came in at -$169 million (Q1 2026), -$113.28 million (Q4 2025) and -$170.89 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Ultragenyx Pharmaceutical | 1.48 Bn | -321.29 Mn | 180.00 Mn | -75.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -75.00 Mn |
| Mar 31, 2026 | -169.00 Mn |
| Dec 31, 2025 | -113.28 Mn |
| Sep 30, 2025 | -170.89 Mn |
| Jun 30, 2025 | -108.00 Mn |
| Mar 31, 2025 | -143.00 Mn |
| Dec 31, 2024 | -122.31 Mn |
| Sep 30, 2024 | -131.99 Mn |
| Jun 30, 2024 | -116.36 Mn |
| Mar 31, 2024 | -165.35 Mn |
| Dec 31, 2023 | -121.84 Mn |
| Sep 30, 2023 | -145.10 Mn |
| Jun 30, 2023 | -147.96 Mn |
| Mar 31, 2023 | -154.11 Mn |
| Dec 31, 2022 | -145.63 Mn |
| Sep 30, 2022 | -225.07 Mn |
| Jun 30, 2022 | -141.59 Mn |
| Mar 31, 2022 | -136.63 Mn |
| Dec 31, 2021 | -102.56 Mn |
| Sep 30, 2021 | -89.83 Mn |
API Access
Ultragenyx Pharmaceutical Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=RARE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "RARE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=RARE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();